Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets.
Wouter Tobias van HaaftenTjasso BlokzijlHendrik Sijbrand HofkerPeter OlingaGerard DijkstraRuud A BankMiriam BoersemaPublished in: Therapeutic advances in gastroenterology (2020)
Expression of genes involved in collagen metabolism in intestinal fibrosis affected terminal ileum of patients with CD reveals a plethora of drug targets. Inhibition of post-translational modification and altering collagen metabolism might attenuate fibrosis formation in the intestine in CD. Which compound has the highest potential depends on a combination anti-fibrotic efficacy and safety, especially since some of the enzymes play key roles in the physiology of collagen.